Stocks TelegraphStocks Telegraph
Stock Ideas

PRPH Company Profile and Key Details

NASDAQ : PRPH

ProPhase Labs, Inc.

$0.33
-0.015-4.41%
Open: 4:00 PM
72.48
BESG ScoreESG Rating

PRPH Stock Price Chart

Stock Price Today

ProPhase Labs, Inc. (PRPH) stock declined over -4.41%, trading at $0.33 on NASDAQ, down from the previous close of $0.34. The stock opened at $0.29, fluctuating between $0.28 and $0.40 in the recent session.

Stock Snapshot

0.34
Prev. Close
0.29
Open
9.71M
Market Cap
29.87M
Number of Shares
0.2751
Day Low
0.4
Day High
-0.21
P/E Ratio
86.04%
Free Float in %
-1.53
EPS (TTM)
2.74
Book Value
-0.8
Cash Flow per Share
12.64M
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Feb 14, 20250.280.400.280.3312.62M
Feb 13, 20250.400.460.320.34146.97M
Feb 12, 20250.250.290.250.28582.66K
Feb 11, 20250.270.290.250.26433.32K
Feb 10, 20250.260.270.240.26444.37K
Feb 07, 20250.260.280.250.26308.5K
Feb 06, 20250.260.290.250.26735.43K
Feb 05, 20250.220.270.220.261.33M
Feb 04, 20250.260.270.230.241.55M
Feb 03, 20250.270.290.220.2715.07M
Jan 31, 20250.410.410.260.26900.5K
Jan 30, 20250.440.440.410.42145.13K
Jan 29, 20250.460.530.410.45528.6K
Jan 28, 20250.450.470.410.46201.4K
Jan 27, 20250.560.560.440.45283.44K
Jan 24, 20250.490.580.440.54273.85K
Jan 23, 20250.490.540.480.49343.7K
Jan 22, 20250.610.620.460.511.06M
Jan 21, 20250.600.630.590.61447.01K
Jan 17, 20250.620.620.580.60182.32K

Contact Details

Garden City, NY 11530

United States

Website: https://www.prophaselabs.comContact: 215 345 0919

About Company

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Company Information

Employees113
Beta-0.1
Sales or Revenue$44.38M
5Y Sales Change%1.239%
Fiscal Year EndsDecember
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Frequently Asked Questions

What is the current ProPhase Labs, Inc. (PRPH) stock price?

ProPhase Labs, Inc. (NASDAQ: PRPH) stock price is $0.33 in the last trading session. During the trading session, PRPH stock reached the peak price of $0.40 while $0.28 was the lowest point it dropped to. The percentage change in PRPH stock occurred in the recent session was -4.41% while the dollar amount for the price change in PRPH stock was -$0.02.

PRPH's industry and sector of operation?

The NASDAQ listed PRPH is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. ProPhase Labs, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PRPH?

Mr. Jason Karkus
Pres of ProPhase Diagnostics
Mr. Ted William Karkus
Chairman & Chief Executive Officer
Ms. Monica Brady
Chief Accounting Officer
Mr. Billy Joe White
Consultant
Mr. Sergio Miralles
Executive Vice President & Chief Information Officer of ProPhase Diagnostics
Mr. Kamal Obbad
Senior Vice President and Director of Sales & Marketing - Nebula Genomics
Mr. Robert A. Morse Jr.
Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer
Mr. Sam A. Beeler
Chief Strategy Officer of Nebula Genomics
Ms. Alice Lioi
EVice President & Chief Operating Officer of ProPhase Diagnostics and ProPhase BioPharma
Mr. Dennis Grishin
Chief Scientific Officer of Nebula Genomics

How PRPH did perform over past 52-week?

PRPH's closing price is 47.73% higher than its 52-week low of $0.22 where as its distance from 52-week high of $7.48 is -95.66%.

How many employees does PRPH have?

Number of PRPH employees currently stands at 113.

Link for PRPH official website?

Official Website of PRPH is: https://www.prophaselabs.com

How do I contact PRPH?

PRPH could be contacted at phone 215 345 0919 and can also be accessed through its website. PRPH operates from 711 Stewart Avenue, Garden City, NY 11530, United States.

How many shares of PRPH are traded daily?

PRPH stock volume for the day was 12.64M shares. The average number of PRPH shares traded daily for last 3 months was 3.28M.

What is the market cap of PRPH currently?

The market value of PRPH currently stands at $9.71M with its latest stock price at $0.33 and 29.87M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph